Mark Kirkland - Medical Director
Mark Kirkland is Associate Professor at the Institute of Technology, Research and Innovation at Deakin University.
is a specialist haematologist with more than 25 years research experience in the field of haemopoietic stem cell biology and 15 years experience as a clinical and laboratory haematologist.
A former Medical Director of Research for the Australian Red Cross Blood Service in Victoria, he has extensive experience in tissue banking, both public and private cord blood banking, and bone banking.
He was also a member of the committee that developed the Australian (NPAAC) Guidelines for Haemopoietic Stem Cells.
He is the Chief Scientific Officer of Cytomatrix Pty Ltd, a biotechnology company specialising in novel technologies for the growth and expansion of human adult stem cells.
has been instrumental in the design and development of Cell Care
's Clinical Trial program, and in particular has instigated the proposed Australia-wide trial in the use of cord blood to prevent the progression of type 1 diabetes.
Professor Mark Kirkland